ABOS - Acumen Pharmaceuticals, Inc. -  [ ]

Ticker Details
Acumen Pharmaceuticals, Inc.
IPO Date: July 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $155.67M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 3.76%
Avg Daily Range (30 D): $0.11 | 4.61%
Avg Daily Range (90 D): $0.09 | 4.22%
Institutional Daily Volume
Avg Daily Volume: .36M
Avg Daily Volume (30 D): .94M
Avg Daily Volume (90 D): .46M
Trade Size
Avg Trade Size (Sh.): 124
Avg Trade Size (Sh.) (30 D): 162
Avg Trade Size (Sh.) (90 D): 168
Institutional Trades
Total Institutional Trades: 60
Avg Institutional Trade: $2.13M
Avg Institutional Trade (30 D): $1M
Avg Institutional Trade (90 D): $1M
Avg Institutional Trade Volume: .39M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.31M
Avg Closing Trade (30 D): $3.8M
Avg Closing Trade (90 D): $3.8M
Avg Closing Volume: 640.1K
 
News
Nov 5, 2025 @ 9:00 PM
Acumen Pharmaceuticals to Report Third Quarter 202...
Source: Acumen Pharmaceuticals
Aug 26, 2025 @ 8:00 PM
Acumen Pharmaceuticals to Participate in Upcoming ...
Source: Acumen Pharmaceuticals
Aug 5, 2025 @ 8:00 PM
Acumen Pharmaceuticals to Report Second Quarter 20...
Source: Acumen Pharmaceuticals
Jul 10, 2025 @ 12:00 PM
Acumen Pharmaceuticals to Present Studies on Cost ...
Source: Acumen Pharmaceuticals
May 7, 2025 @ 8:00 PM
Acumen Pharmaceuticals to Participate in the Bank ...
Source: N/A
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-.44 $-.68 $-.48
Diluted EPS $-.44 $-.68 $-.48
Revenue $M $M $M
Gross Profit
Net Income / Loss $-26.45M $-40.95M $-28.8M
Operating Income / Loss $-26.51M $-41.75M $-30.37M
Cost of Revenue
Net Cash Flow $10.02M $6.65M $-5.47M
PE Ratio